Trials / Terminated
TerminatedNCT01701466
Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis
A Phase II Study Designed to Evaluate the Value of Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis for Patients Undergoing External Radiation Therapy
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether NeoVIDERM is effective at preventing radiation dermatitis in patients receiving external beam radiation therapy to the head and neck or breast areas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Aveeno cream | Twice a day |
| OTHER | Flamazine cream | Twice a day, when there is dry desquamation |
| OTHER | NeoVIDERM cream | Three times a day |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-05-01
- First posted
- 2012-10-05
- Last updated
- 2015-05-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01701466. Inclusion in this directory is not an endorsement.